Snore Lab

Disease Category:
Target Audience:

Clinical Relevance
Version: 3.6
Developer: Reviva Softworks, Ltd
Review Date: 2016-04-23
Cost: Free + Pro version (paid)

Overall App Summary:

SnoreLab will be of interest to people (and their bed partners!) who snore. There is not a direct clinical benefit, but the app’s mechanisms to reduce snoring are fairly logical: monitor snoring, modify the user’s snoring risk factors, and monitor snoring again to determine if there was a benefit. A simple app clinical trial would go a long way for this app. One word of caution on this app: Self-managing snoring can be risky without first being evaluated by a physician – snoring can be linked to important medical conditions.


App’s Intended Use:

SnoreLab provides means to record and monitor snoring, allowing the user modify behavior and trial interventions to alter snoring. It is a reasonable tool for those who are self-motivated and to track sleep and snoring. While minimizing snoring does not necessarily correlate to better sleep, it is part of a formal sleep evaluation and will be of interest to the general snorer. If SnoreApp can serve as a behavioral tool, then may be helpful for behaviors or habits that affect snoring. It is not true diagnostic app as is partly claimed by its makers. Thus, it may give users a false sense of security or the reverse.


Who’s this app most useful for?

This app is useful the snorer, their bed partner, or their caregiver. It may provide validation for the bed partner or caregiver.


How should one use it?

Snorers should use the app nightly to monitor their snoring, ideally in a setting where a bed partner’s snoring will not confound the monitoring. After snoring monitoring, the user reviews the snore reports, determines if any snoring risk factors can be modified, modifies them, and then determines if snoring is reduced.


Why should anyone use this app? Is it clinically relevant?

The clinical benefits of this application are only indirect and inferred. In other words, there are various sleep risk factors, including obesity and exercise frequency, which can be modified and result in better health and possibly, less snoring. Although there is not a clear clinical benefit from the app, it’s a fairly logical approach to snoring monitoring and snoring reduction.


Is there any published evidence that the app actually works?

The reviewers could not find any clinical evidence demonstrating the effectiveness of the Snore Lab app. However, the reviewers believe that a clinical trial would be straight forward, simple and much needed!


Regulatory Compliance




What is the most important/ desirable feature of the app?

The snoring recording mechanism, playback reports, and data review are intuitive and relevant to the intended purpose of the app. We really like the interface of the app – it is has a pleasing functional design.


How is the app’s usability?

The usability of the app is better than it’s clinical utility. It is fairly easy to use and it has an appealing look and feel. The app also has several features, but it is fairly intuitive.


How does this app compare to others in the category?

This is a top app for snoring evaluation, setting it apart from many other sleep apps with different indications or intended uses.


If there’s a paid version, is it worth the upgrade?

The free version is useful, but many users may find the upgrade to be worth the cost as it provides much of the same free features, but in more depth, including a longer report history, better data analysis (e.g. comparison charts) and importantly, unlimited usage.


Ayesha Khalid

Ayesha is an ENT surgeon at Harvard Medical School with an MBA in Global Leadership and Innovation from the MIT Sloan School of Management. Ayesha serves on several Boards for medical organizations and is currently on the board of the American Academy of Otolaryngology- Head and Neck Surgery. Ayesha has experience with consulting for private equity firms to evaluate business opportunities in the health IT and medical practice management. She served as Vice-President of Business Development of a digital health start-up out of Johns Hopkins, Doctella. Presently, in addition to clinical practice, Ayes is the Clinician Director for CBIT at the Yale School of Medicine and is curating early stage health IT startups. You can follow Ayesha on Twitter at @ayeshakhalidmd

Conflicts of Interest

Employment: Cambridge Hospital and Harvard Medical School; Yale School of Medicine; Consultant/ Advisor: 480 Biomedical, Stallergenes Greer, Smith and Nephew, Lambay Advisors, Burr Pilgrim Mayer; Ownership: 480 Biomedical, Collective Healthtech, GeoHealth

Adam Cohen

Dr. Adam B. Cohen, a Michigan native, is a neurologist & neuro-ophthalmologist at Massachusetts General Hospital in Boston, Massachusetts, where he is the Neurology Inpatient Medical Director and TeleNeurology Co-Director. He focuses on process innovation, digital health, and improving the efficiency of specialty health care delivery.

Conflicts of Interest:

Employment: Massachusetts General Hospital and Harvard Medical School; Consultant/ Advisor: Decibel Therapeutics, EM Gladiators LLC; Ownership: Expertaj; Research: Academic only; no private funding.

Maulik Majmudar

Dr. Maulik Majmudar is a practicing cardiologist and Associate Director of the Healthcare Transformation Lab at Massachusetts General Hospital; and an Instructor at Harvard Medical School. He lectures at Massachusetts Institute of Technology in areas of healthcare innovation & entrepreneurship, as well as medical device design and development. Dr. Majmudar started his career as a medical student at Northwestern University Feinberg School of Medicine, completed resident training in Internal Medicine at The Johns Hopkins Hospital, and followed by a fellowship in Cardiovascular Medicine at Brigham and Women's Hospital at Harvard Medical School. You can follow him @mmajmudar

Conflicts of Interest:

Employment: Massachusetts General Hospital and Harvard Medical School; Consultant/ Advisor: AliveCor, BioFourmis, Cardiogram, EchoSense, Facebook, HUINNO, MC10, Nokia; Ownership: BioFourmis, Cardiogram, HiLabs, Quanttus; Research: EchoSense, GE Healthcare, MIT.

Leave a Reply

Your email address will not be published. Required fields are marked *